Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies

Griffin, J. M., Baughan, E., Rosenblum, H., Clerkin, K. J., Fried, J. A., Raikhelkar, J., Uriel, N., Brannagan, T. H., Takeda, K., Grodin, J. L., Marboe, C., Maurer, M. S., & Farr, M. A. (2022). Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies. The Journal of Heart and Lung Transplantation, 41(2), 199–207. https://doi.org/10.1016/j.healun.2021.10.007
Authors:
Jan M. Griffin
Eleonore Baughan
Hannah Rosenblum
Kevin J. Clerkin
Justin A. Fried
Jayant Raikhelkar
Nir Uriel
Thomas H. Brannagan
Koji Takeda
Justin L. Grodin
Charles Marboe
Mathew S. Maurer
Maryjane A. Farr
Affiliated Authors:
Jan M. Griffin
Eleonore Baughan
Hannah Rosenblum
Kevin J. Clerkin
Justin A. Fried
Jayant Raikhelkar
Nir Uriel
Thomas H. Brannagan
Koji Takeda
Charles Marboe
Mathew S. Maurer
Maryjane A. Farr
Author Keywords:
heart transplantation, disease progression, transthyretin amyloidosis, surveillance, transthyretin stabilizers
heart transplantation
disease progression
transthyretin amyloidosis
surveillance
transthyretin stabilizers
Publication Type:
Article
Unique ID:
10.1016/j.healun.2021.10.007
PMID:
Publication Date:
Data Source:
Scopus

Record Created: